Pfizer Continues its Pursuit of Rare Disease Therapies with Zacharon Collaboration
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 4 (Table of Contents)
Published: 26 Apr-2011
DOI: 10.3833/pdr.v2011.i4.1463 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Pfizer’s Orphan and Genetic Disease Research Unit, which was established in July 2010, has struck its first drug discovery deal, thus continuing the company’s foray into rare diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS